主题：ABS多特异性抗体平台及案例分析

时间：2021年7月7日 周三  20:30-21:30

Dr. Yue Liu   AB Studio Inc. 创始人& CEO

Dr. Yue Liu has more than 20 years of experience in therapeutic antibody research and development and more than ten years of experience in computer aided therapeutic antibody design. She has led and participated in multiple therapeutic antibody studies on various diseases, including the development of anti-thrombotic antibodies for thrombi imaging and antibody targeted thrombolysis, bispecific, tri-specific antibodies and antibody drug conjugates to target cancer, anti-syn and anti-Tau antibodies for targeting PD and AD, as well as antibodies to target AMD and rare diseases.

Dr. Liu is holding Ph.D. in microbiology and infectious diseases from Universite de Sherbrooke, Canada; M.Sc. in internal medicine from Soochow University, China and B.Sc. in biology from Nanjing University, China. She is the author and co-author of multiple scientific publications and inventors of multiple patent and patent applications.